Oncogene - Table of Contents alert Volume 37 Issue 21

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 37, Issue 21 In this issue Article Also new AOP Article Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells Kei Takahashi, Shogo Ehata, Daizo Koinuma, Yasuyuki Morishita, Manabu Soda et al. Oncogene 2018 37 :2757 - 2772; March 07, 2018; 10.1038/s41388-018-0144-0 Abstract | Full Text TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression Xiaomeng Li, Xianhui Ruan, Peitao Zhang, Yang Yu, Ming Gao et al. Oncogene 2018 37 :2773 - 2792; March 07, 2018; 10.1038/s41388-017-0090-2 Abstract | Full Text PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53 Qi Liu, Liliana Gheorghiu, Michael Drumm, Rebecca Clayman, Alec Eidelman et al. Oncogene 2018 37 :2793 - 2805; March 07, 2018; 10.1038/s41388-018-0130-6 Abstract | Full Text Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner Louise Dubuisson, Florence Lormières, Stefania Fochi, Jocelyn Turpin, Amandine Pasquier et al. Oncogene 2018 37 :2806 - 2816; March 06, 2018; 10.1038/s41388-018-0163-x Abstract | Full Text Regulation of inside-out ß1-integrin activation by CDCP1 Sara G. Pollan, Fangjin Huang, Jamie M. Sperger, Joshua M. Lang, Colm Morrissey et al. Oncogene 2018 37 :2817 - 2836; March 07, 2018; 10.1038/s41388-018-0142-2 Abstract | Full Text Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor Yu Zhu, Luo Lu, Chun Qiao, Yi Shan, Huapeng Li et al. Oncogene 2018 37 :2837 - 2849; March 07, 2018; 10.1038/s41388-018-0157-8 Abstract | Full Text Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma Sara Bolin, Anna Borgenvik, Camilla U. Persson, Anders Sundström, Jun Qi et al. Oncogene 2018 37 :2850 - 2862; March 07, 2018; 10.1038/s41388-018-0135-1 Abstract | Full Text The Rbm38-p63 feedback loop is critical for tumor suppression and longevity Yuqian Jiang, Enshun Xu, Jin Zhang, Mingyi Chen, Elsa Flores et al. Oncogene 2018 37 :2863 - 2872; March 09, 2018; 10.1038/s41388-018-0176-5 Abstract | Full Text Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10 Lili Bao, Bo You, Si Shi, Ying Shan, Qicheng Zhang et al. Oncogene 2018 37 :2873 - 2889; March 09, 2018; 10.1038/s41388-018-0183-6 Abstract | Full Text microRNA-200a downregulation in human glioma leads to Gai1 over-expression, Akt activation, and cell proliferation Yuan-yuan Liu, Min-Bin Chen, Long Cheng, Zhi-qing Zhang, Zheng-quan Yu et al. Oncogene 2018 37 :2890 - 2902; March 09, 2018; 10.1038/s41388-018-0184-5 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.